Institute of Psychotherapy and Psychosomatic Medicine, School of Medicine, Technische Universität Dresden, Fetscherstr. 74, 01307 Dresden, Germany.
Psychoneuroendocrinology. 2010 Apr;35(3):414-21. doi: 10.1016/j.psyneuen.2009.08.003. Epub 2009 Nov 12.
Subtle and inconsistent differences in hypothalamic-pituitary-adrenal (HPA) axis activity have been reported for patients with panic disorder. While these patients show little or no alterations in basal ACTH and cortisol levels, it has been hypothesized that HPA hyperresponsivity was a trait in panic patients when exposed to novel and uncontrollable stimulation.
Thirty-four patients (23 females, mean age 35 yrs) diagnosed with panic disorder were compared to 34 healthy controls matched for age, gender, smoking status, and use of oral contraceptives. Both groups were exposed twice to a potent laboratory stress protocol, the Trier Social Stress Test (TSST) on consecutive days. Free salivary cortisol levels and heart rate responses were repeatedly measured before and following the TSST. In addition, the cortisol awakening response (CAR) was assessed to further investigate HPA reactivity in PD patients.
While the TSST induced similar heart rate stress responses in both groups, cortisol responses were clearly absent in the panic patients with normal responses in the controls (F(1.96, 66)=20.16; p<0.001). No differences in basal cortisol levels were observed in the extended baseline period. The same cortisol stress non-response patterns were observed when patients with/without comorbid depression, or with/without psychotropic medication were compared. In contrast to their non-response to the psychosocial stressor, panic patients showed a significant CAR.
These findings provide strong evidence to suggest that PD patients present with a striking lack of cortisol responsivity to acute uncontrollable psychosocial stress under laboratory conditions. This unresponsiveness of the HPA axis appears to be rather specific, since a normal CAR in the morning could be documented in these patients. Thus, the present results do not support the hypothesis that PD patients show a trait HPA hyperresponsiveness to novel and uncontrollable stimulation. In contrast, the data provide support for a hyporesponsive HPA axis under emotional stress in PD patients.
据报道,患有惊恐障碍的患者在下丘脑-垂体-肾上腺(HPA)轴活动方面存在微妙且不一致的差异。尽管这些患者的基础 ACTH 和皮质醇水平几乎没有或没有改变,但有人假设,当惊恐障碍患者暴露于新的不可控刺激时,HPA 高反应性是一种特征。
将 34 名被诊断为惊恐障碍的患者(23 名女性,平均年龄 35 岁)与 34 名年龄、性别、吸烟状况和使用口服避孕药相匹配的健康对照进行比较。两组均在连续两天接受了一项有力的实验室应激方案,即特里尔社会应激测试(TSST)。在 TSST 前后多次重复测量游离唾液皮质醇水平和心率反应。此外,还评估了皮质醇觉醒反应(CAR),以进一步研究 PD 患者的 HPA 反应性。
虽然 TSST 在两组中引起了相似的心率应激反应,但惊恐障碍患者的皮质醇反应明显缺失,而对照组的皮质醇反应正常(F(1.96, 66)=20.16;p<0.001)。在扩展的基线期内未观察到基础皮质醇水平的差异。当比较伴有/不伴有共病抑郁的患者或伴有/不伴有精神药物的患者时,观察到相同的皮质醇应激无反应模式。与他们对心理社会应激源的无反应相反,惊恐障碍患者表现出明显的 CAR。
这些发现提供了强有力的证据表明,惊恐障碍患者在实验室条件下对急性不可控的心理社会应激表现出明显缺乏皮质醇反应性。HPA 轴的这种无反应性似乎相当特异,因为可以在这些患者的早上记录到正常的 CAR。因此,目前的结果并不支持惊恐障碍患者对新的不可控刺激表现出特质性 HPA 高反应性的假设。相反,数据支持惊恐障碍患者在情绪应激下 HPA 轴低反应性的假说。